PLATELET SECRETION DEFECT ASSOCIATED WITH IMPAIRED LIBERATION OF ARACHIDONIC-ACID AND NORMAL MYOSIN LIGHT CHAIN PHOSPHORYLATION

Authors:
  • ARAK RAO
    AK RAO
  • KKK KOIKE
    K KOIKE
  • JWJ WILLIS
    J WILLIS
  • JDJL DANIEL
    JL DANIEL
  • CBC BECKETT
    C BECKETT
  • BHB HASSEL
    B HASSEL
  • HDHJ DAY
    HJ DAY
  • JSJB SMITH
    JB SMITH
  • HHH HOLMSEN
    H HOLMSEN

  • 1 January 1984
    • journal article
    • research article
    • Vol. 64  (4) , 914-921
    • PMID:6089937
Abstract
Four patients with impaired platelet aggregation and 14C-serotonin [5-hydroxytryptamine, 5-HT] secretion during stimulation with ADP, epinephrine, collagen and platelet-activating factor are described. The response to arachidonic acid was normal in all patients with regard to aggregation and in 3 of the 4 with regard to 14C-5-HT secretion. The total platelet ATP and ADP content and the ATP to ADP ratio was normal in all patients, thereby excluding storage pool deficiency as the cause of the secretion defect. Studies with 3H-arachidonic acid-labeled platelets revealed that the thrombin-induced liberation of arachidonic acid from membrane-bound phospholipids was impaired in these patients. Platelet thromboxane B2 production, measured using a radioimmunoassay, was diminished during stimulation with ADP and thrombin, but was normal with arachidonic acid, indicating that the oxygenation of arachidonic acid was normal and that the diminished thromboxane production was due to a defect in the liberation of arachidonic acid. Release of arachidonic acid is mediated by phospholipases that are Ca2+ dependent. To examine whether these patients may have a defect in making intracellular Ca2+ available, another Ca2+-dependent process, myosin light chain phosphorylation, was studied during thrombin stimulation. Platelets from 3 of the patients behave the same as normal ones, suggesting that the deficiency in phospholipase activity may not be due to impaired Ca2+ mobilization. A novel group of patients with platelet secretion defects associated with impaired liberation of arachidonic acid from phospholipids is demonstrated. These patients exemplify a congenital defect, other than deficiencies of cyclooxygenase and thromboxane synthetase, by which thromboxane production may be impaired in platelets.